These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. HLA-D region-associated determinants serve as targets for human cell-mediated lysis. Feighery C; Stastny P J Exp Med; 1979 Feb; 149(2):485-94. PubMed ID: 84045 [TBL] [Abstract][Full Text] [Related]
3. Absence of allogeneic restriction in human T-cell-mediated cytotoxicity to Epstein-Barr virus-infected target cells. Demonstration of an HLA-linked control at the effector level. Lipinski M; Fridman WH; Tursz T; Vincent C; Pious D; Fellous M J Exp Med; 1979 Dec; 150(6):1310-22. PubMed ID: 229186 [TBL] [Abstract][Full Text] [Related]
4. Cell-mediated cytotoxicity against HLA-D-region products expressed in monocytes and B lymphocytes. I. Blocking by Unlabelled cells and inhibition by antisera. Feighery CF; Stastny P Immunogenetics; 1980; 10(1):31-8. PubMed ID: 6157642 [TBL] [Abstract][Full Text] [Related]
5. Cell-mediated cytotoxicity against HLA-D-region products expressed in monocytes and B lymphocytes. II. HLA-A- or B-antigen compatibility is not required for HLA-D-region directed cytotoxicity. Feighery CF; Stastny P Immunogenetics; 1980; 10(1):39-43. PubMed ID: 6967856 [TBL] [Abstract][Full Text] [Related]
7. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis. Strang G; Rickinson AB Eur J Immunol; 1987 Jul; 17(7):1007-13. PubMed ID: 2440688 [TBL] [Abstract][Full Text] [Related]
8. Cell mediated cytotoxicity against HLA-D region products expressed in monocytes and B lymphocytes. III. Inhibition by monoclonal antibodies and study of an HLA-B/DR recombinant. Ball EJ; Feighery CF; Stastny P Hum Immunol; 1981 Jul; 2(4):305-13. PubMed ID: 6974159 [TBL] [Abstract][Full Text] [Related]
9. HLA identical leukemia cells and T cell growth factor activate cytotoxic T cell recognition of minor locus histocompatibility antigens in vitro. Sondel PM; Hank JA; Wendel T; Flynn B; Bozdech MJ J Clin Invest; 1983 Jun; 71(6):1779-86. PubMed ID: 6223050 [TBL] [Abstract][Full Text] [Related]
10. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity. de Vries JE; Spits H J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458 [TBL] [Abstract][Full Text] [Related]
11. Typing by cytotoxic lymphocytes. Genetics of HLA-non-A, B, C determinants - family studies. Kristensen T; Johnsen HE; Mossin J; Jørgensen F; Lamm LU; Kissmeyer-Nielsen F Tissue Antigens; 1981 May; 17(5):455-63. PubMed ID: 6461089 [TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-induced lymphoblastoid cell lines from seropositive adult donors and their HLA-antigens. Akiyama N; Ohsawa N; Kusaba R; Inou T; Takada M Jpn J Exp Med; 1981 Feb; 51(1):1-7. PubMed ID: 6273617 [TBL] [Abstract][Full Text] [Related]
13. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines. Masucci MG; Torsteindottir S; Colombani J; Brautbar C; Klein E; Klein G Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4567-71. PubMed ID: 3037521 [TBL] [Abstract][Full Text] [Related]
14. Cytotoxic T cells from a human chimera induce regression of Epstein-Barr virus-infected allogeneic host cells. Plotnicky H; Touraine JL Int Immunol; 1993 Nov; 5(11):1413-20. PubMed ID: 8260455 [TBL] [Abstract][Full Text] [Related]
15. HLA antigen-related restriction of T lymphocyte cytotoxicity to Epstein-Barr virus. Misko IS; Moss DJ; Pope JH Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4247-50. PubMed ID: 6254017 [TBL] [Abstract][Full Text] [Related]
16. Genetics of cell-mediated lympholysis in man. Geha RS; Malakian A; Geha O; Yunis E J Immunol; 1977 Apr; 118(4):1286-91. PubMed ID: 66285 [TBL] [Abstract][Full Text] [Related]
17. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice. Lacerda JF; Ladanyi M; Louie DC; Fernandez JM; Papadopoulos EB; O'Reilly RJ J Exp Med; 1996 Mar; 183(3):1215-28. PubMed ID: 8642263 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches. Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879 [TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-specific cytotoxic T lymphocytes as probes of HLA polymorphism. Heterogeneity of T cell-restricting determinants associated with the serologically defined HLA-A2 antigen. Gaston JS; Rickinson AB; Epstein MA J Exp Med; 1983 Aug; 158(2):280-93. PubMed ID: 6193217 [TBL] [Abstract][Full Text] [Related]
20. Expression of HLA antigens on renal tubular cells in culture. II. Effect of increased HLA antigen expression on tubular cell stimulation of lymphocyte activation and on their vulnerability to cell-mediated lysis. Bishop GA; Waugh JA; Hall BM Transplantation; 1988 Aug; 46(2):303-10. PubMed ID: 2970135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]